All statins — hydrophilic or lipophilic — reach the brain in steady state and can reduce cholesterol synthesis there. Meta-analyses show statins are either neutral or beneficial for dementia risk, but some patients develop brain fog, which may reflect over-suppression. Plasma desmosterol can help calibrate the dose.